Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Appelbaum

Showing results (91-100 of 258) with videos related to

Pageof 26
Sort By:
Drugs|January 1, 1995
Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococciG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1992
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacinS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|August 1, 1990
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centersP C Appelbaum, S K Spangler, M R Jacobs
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methodsL M Ednie, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|September 1, 1994
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyG A Pankuch, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobesS K Spangler, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|August 1, 1993
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactamP C Appelbaum, S K Spangler, M R Jacobs
Journal of Clinical Microbiology|June 1, 1985
Accuracy and reproducibility of a four-hour method for anaerobe identificationP C Appelbaum, C S Kaufmann, J W Depenbusch
Journal of Clinical Microbiology|November 18, 1998
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologiesC L Clark, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|February 1, 1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciM A Visalli, M R Jacobs, P C Appelbaum
Pageof 26

Showing results (91-100 of 258) with videos related to

Sort By:
Pageof 26
Drugs|January 1, 1995
Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococciG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1992
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacinS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|August 1, 1990
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centersP C Appelbaum, S K Spangler, M R Jacobs
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methodsL M Ednie, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|September 1, 1994
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyG A Pankuch, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobesS K Spangler, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|August 1, 1993
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactamP C Appelbaum, S K Spangler, M R Jacobs
Journal of Clinical Microbiology|June 1, 1985
Accuracy and reproducibility of a four-hour method for anaerobe identificationP C Appelbaum, C S Kaufmann, J W Depenbusch
Journal of Clinical Microbiology|November 18, 1998
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologiesC L Clark, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|February 1, 1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciM A Visalli, M R Jacobs, P C Appelbaum
Pageof 26